Karyotype profiles in chronic myelogenous leukaemia. Influence of therapy and progression of disease.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002869:Chromosome Aberrations; D025063:Chromosome Disorders; D006801:Humans; D007621:Karyotyping; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D013223:Statistics as Topic
D000970:Antineoplastic Agents